{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-019337","form_type":"8-K","ticker":"SGMO","cik":"0001001233","company_name":"SANGAMO THERAPEUTICS, INC","filed_at":"2024-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.790747+00:00","generated_at":"2026-06-03T03:51:11.977292+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Sangamo receives Nasdaq deficiency notice for bid price below $1 per share","bullets":["Notice received April 24, 2024; stock closed below $1 for 30 consecutive business days.","Company has 180 calendar days until October 21, 2024 to regain compliance.","If not compliant, may transfer to Nasdaq Capital Market for an additional 180-day period.","Evaluating options including a potential reverse stock split to cure the deficiency."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-019337","json":"https://secwatch.observer/filing/0001628280-24-019337.json","markdown":"https://secwatch.observer/filing/0001628280-24-019337.md","text":"https://secwatch.observer/filing/0001628280-24-019337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024019337/0001628280-24-019337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024019337/sgmo-20240424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T03:51:11.977292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9fc8da0dd4c74432b56a0f3c53a876e1d9a001c9","claim":"SANGAMO THERAPEUTICS, INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).","evidence_excerpt":"April 24, 2024, Sangamo Therapeutics, Inc. (the “Company”) received a deficiency notice, or the Notice, from the Listing Qualifications Staff, or the Staff, of The Nasdaq Stock Market LLC, or Nasdaq, notifying the Company that, for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing bid price required by the continued listing requirements of Nasdaq Listing Rule 5450(a)(1). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Global Select Market. In accordance with Nasd","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1001233/000162828024019337/0001628280-24-019337-index.htm","confidence":0.99,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5450(a)(1), 5810(c)(3)(A)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}